Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-08-09
1996-03-05
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514264, A61K 3152
Patent
active
054968232
ABSTRACT:
Pharmaceutical compositions for the improvement of dysuria comprising a pharmaceutical carrier and a therapeutically effective amount of a xanthine derivative represented by the general formula I ##STR1## wherein R.sub.1 denotes a group of the formula R.sub.4 -CO- or R.sub.5 R.sub.6 (OH)C- or a carboxyl group, wherein R.sub.4 and R.sub.5 independently denote an alkyl group having 1-3 carbon atoms, and R.sub.6 denotes a hydrogen atom or an alkyl group having 1-3 carbon atoms, R.sub.2 denotes a hydrogen atom, an alkyl group having 1-5 carbon atoms or an alkyloxy group having 1-5 carbon atoms, R.sub.3 denotes an alkyl group having 1-3 carbon atoms and n denotes 1-6 or a pharmaceutically acceptable acid addition salt thereof.
They are active in prolonging urination intervals and increasing urination threshold pressure with almost no influence upon constrictive force of the bladder. Thus, they are effective in treatment and prevention of dysuria such as pollakiuria and incontinence of urine.
REFERENCES:
patent: 4289776 (1981-09-01), Mohler et al.
Drugs of the Future, vol. VII, No. 2, 1982, "Propentofgylline", pp. 119-120.
Morikawa et al., Pharmacometrics, vol. 37, No. 1, pp. 27-37 (1989).
Journal of New Remedies & Clinics (Shin-yaku to Rinsho) vol. 38 No. 12, pp. 133-138 (Dec. 1989), Kimura et al.
Pharmacometrics (Oyu Yakuri) vol. 30, No. 4, pp. 661-676 (p. 661, summary item 2 and p. 673 tables 13 and 14), Sakurai et al., 1985.
Chemical Abstracts 95(23):197310s, 1981.
Chemical Abstracts 110(15):128285d, 1988.
Chemical Abstracts 116(21):209267a, 1991.
Goodman Gilman et al. "The Pharmacological Basis of Therapeutics" (6th Ed.) New York, MacMillan Publishing, 1980, pp. 924-925.
Morioka Yuko
Takano Mitsuru
Cintins Marianne M.
Hoechst Japan Limited
Moezie M.
LandOfFree
Pharmaceutical composition for increasing bladder capacity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for increasing bladder capacity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for increasing bladder capacity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1413078